Trials / Completed
CompletedNCT03093363
Impact of a Hospital Pharmacist's Intervention on FENO (Fractional Exhaled Nitric Oxide) in Asthmatic Patients
Study of the Impact of a Hospital Pharmacist's Intervention in Collaboration With Pneumologists on Bronchial Inflammation of Outpatient Asthmatic Patients Seen in University Hospital of Liege
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- University of Liege · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The impact of a pharmacist's intervention on asthma control has now been well demonstrated, but its effect on inflammatory markers of FENO (Fractional exhaled nitric oxide) in asthmatic patients has been little studied in the literature. The aim of this study is to investigate the impact of a pharmacist's intervention on FENO in patients seen in clinical practice by a pneumologist in a secondary university center.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pharmacist's intervention | Pharmacist's intervention with asthmatic patients: * Detailed questionnaire on asthma and treatments (atopy, comorbidities, smoking status, asthma control, adverse effects of treatments, etc.) * Explanation of asthma and inflammation * Explanation of triggers and how to avoid it * Explanation of asthma treatments * Explanation of the inhalation technique with a physical demonstration * Emphasis on treatment adherence * Assessment of comorbidities and their treatment * Emphasis on influenza vaccination |
| OTHER | Questionnaires for control group | \- Detailed questionnaire on asthma and treatments (atopy, comorbidities, smoking status, asthma control, adverse effects of treatments, etc.) |
Timeline
- Start date
- 2016-10-31
- Primary completion
- 2017-04-30
- Completion
- 2017-04-30
- First posted
- 2017-03-28
- Last updated
- 2017-10-25
Source: ClinicalTrials.gov record NCT03093363. Inclusion in this directory is not an endorsement.